Faith and culture expert Alex McFarland spoke to Fox News on the "Lighthouse Faith" podcast about Donald J. Trump's election victory — and the importance of religious voters.

Christian groups in Mumbai have objected to the titles in a book series called "Sex Bible', for sale on the e-commerce site ...

And while members still host Bible studies, post-incarceration transitioning and life skill sessions, the group in recent years has pivoted to prevention work, said Winston Taylor, organizer of ...

When I became converted in 1977 and began attending a non-denominational church, I was reminded that the evil forces were ...

We can see from the definition below that respect means to hold someone or something in high regard. The Bible tells us quite ...

Despite its unique ability to block sodium-glucose linked transporter 2 (SGLT2) in the kidneys and SGLT1 in the intestines, Lexicon’s Zynquista (sotagliflozin) has had difficulty negotiating ...

(RTTNews) - Lexicon Pharmaceuticals Inc. (LXRX) announced that the U.S. Food and Drug Administration's Advisory Committee voted against the company's New Drug Application (NDA) for Zynquista ...

Oct 31 (Reuters) - Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' (LXRX.O), opens new tab add-on treatment to insulin ...

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Lexicon Pharmaceuticals LXRX in the last three months. The following table summarizes their ...

María Pilar Agustín-Llach [Opens in a new window] and The present study delves into the structure and lexical organization of L1 and L2 mental lexicons. Indirect access to the mental lexicon is ...

Lexicon (LXRX) announced that patient screening has been completed in the Phase 2b PROGRESS clinical trial evaluating the company’s AAK1 inhibitor, LX9211, for the treatment of Diabetic ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), with a price target of $10.00. The company’s shares ...